SK Biopharmaceuticals and twoXAR Team to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer

US Food and Drug Administration Approves Duaklir Pressair for Patients with Chronic Obstructive Pulmonary Disease

TherapeuticsMD Launches Bijuva Hormone Therapy in the US

TherapeuticsMD Signs Binding Commitment Letter for USD 300m Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC

The United States Food and Drug Administration approves Narcan

United States Food and Drug Administration approves marketing of Monarch external Trigeminal Nerve Stimulation System

SpeeDx and Cepheid Forge Test Partnership

Sensei Biotherapeutics Names Former Head of the National Cancer Institute to its Board of Directors

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease

US FDA accepts Novartis' biologics license application for brolucizumab

Alnylam Initiates ILLUMINATE-B Phase 3 Pediatric Study of Lumasiran for the Treatment of Primary Hyperoxaluria

WuXi Biologics successfully concludes first US FDA routine GMP Inspection at its facilities

Aprea Therapeutics passes US FDA Fast Track designation for APR-246 to treat MDS with TP53 mutation

Aquestive submits Riluzole Oral Film NDA with US FDA for ALS